These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 32915645)
21. Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease. Gasiuniene E; Lavinskiene S; Sakalauskas R; Sitkauskiene B COPD; 2016 Oct; 13(5):569-75. PubMed ID: 27018873 [TBL] [Abstract][Full Text] [Related]
22. [Airway inflammation and lymphocyte subset analysis in patients with chronic obstructive pulmonary disease and healthy smokers]. Yurdakul AS; Taci Hoca N; Cimen F; Atikcan S; Sipit T; Atasever M; Balci M Tuberk Toraks; 2006; 54(2):122-7. PubMed ID: 16924567 [TBL] [Abstract][Full Text] [Related]
23. Oxidative stress and airway inflammation in severe exacerbations of COPD. Drost EM; Skwarski KM; Sauleda J; Soler N; Roca J; Agusti A; MacNee W Thorax; 2005 Apr; 60(4):293-300. PubMed ID: 15790984 [TBL] [Abstract][Full Text] [Related]
24. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Droemann D; Goldmann T; Tiedje T; Zabel P; Dalhoff K; Schaaf B Respir Res; 2005 Jul; 6(1):68. PubMed ID: 16004610 [TBL] [Abstract][Full Text] [Related]
25. Increased airway granzyme b and perforin in current and ex-smoking COPD subjects. Hodge S; Hodge G; Nairn J; Holmes M; Reynolds PN COPD; 2006 Dec; 3(4):179-87. PubMed ID: 17361498 [TBL] [Abstract][Full Text] [Related]
26. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease. Moré JM; Voelker DR; Silveira LJ; Edwards MG; Chan ED; Bowler RP BMC Pulm Med; 2010 Oct; 10():53. PubMed ID: 20973980 [TBL] [Abstract][Full Text] [Related]
27. Airway regulatory T cells are decreased in COPD with a rapid decline in lung function. Eriksson Ström J; Pourazar J; Linder R; Blomberg A; Lindberg A; Bucht A; Behndig AF Respir Res; 2020 Dec; 21(1):330. PubMed ID: 33317530 [TBL] [Abstract][Full Text] [Related]
28. Protein N-glycosylation in the bronchoalveolar space differs between never-smokers and long-term smokers with and without COPD. Venkatakrishnan V; Thomsson KA; Padra M; Andersson A; Brundin B; Christenson K; Bylund J; Karlsson NG; Lindén A; Lindén SK Glycobiology; 2023 Dec; 33(12):1128-1138. PubMed ID: 37656214 [TBL] [Abstract][Full Text] [Related]
29. Expression of Stress-Induced Genes in Bronchoalveolar Lavage Cells and Lung Fibroblasts from Healthy and COPD Subjects. Garcia-Ryde M; van der Burg NMD; Berlin F; Westergren-Thorsson G; Bjermer L; Ankerst J; Larsson-Callerfelt AK; Andersson CK; Tufvesson E Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928305 [TBL] [Abstract][Full Text] [Related]
30. Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking. Barceló B; Pons J; Ferrer JM; Sauleda J; Fuster A; Agustí AG Eur Respir J; 2008 Mar; 31(3):555-62. PubMed ID: 18057064 [TBL] [Abstract][Full Text] [Related]
31. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Sethi S; Maloney J; Grove L; Wrona C; Berenson CS Am J Respir Crit Care Med; 2006 May; 173(9):991-8. PubMed ID: 16474030 [TBL] [Abstract][Full Text] [Related]
32. TLR4 up-regulation and reduced Foxp3 expression in mechanically ventilated smokers with obstructive chronic bronchitis. Pace E; Ferraro M; Giarratano A; Cipollina C; Gjomarkaj M COPD; 2013 Apr; 10(2):147-55. PubMed ID: 23514217 [TBL] [Abstract][Full Text] [Related]
33. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients. Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703 [TBL] [Abstract][Full Text] [Related]
35. Damage-Associated Molecular Patterns and Myeloid-Derived Suppressor Cells in Bronchoalveolar Lavage Fluid in Chronic Obstructive Pulmonary Disease Patients. Brajer-Luftmann B; Nowicka A; Kaczmarek M; Wyrzykiewicz M; Yasar S; Piorunek T; Sikora J; Batura-Gabryel H J Immunol Res; 2019; 2019():9708769. PubMed ID: 31355298 [TBL] [Abstract][Full Text] [Related]
36. S100A9/CD163 Expression in Circulating Classical Monocytes in Chronic Obstructive Pulmonary Disease. Yamashita M; Utsumi Y; Yamauchi K COPD; 2020 Oct; 17(5):587-594. PubMed ID: 32962431 [TBL] [Abstract][Full Text] [Related]
37. The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD. Ween MP; White JB; Tran HB; Mukaro V; Jones C; Macowan M; Hodge G; Trim PJ; Snel MF; Hodge SJ Sci Rep; 2021 Feb; 11(1):4106. PubMed ID: 33602992 [TBL] [Abstract][Full Text] [Related]